Reducing nighttime light exposure in the urban environment to benefit human health and society.


Journal

Science (New York, N.Y.)
ISSN: 1095-9203
Titre abrégé: Science
Pays: United States
ID NLM: 0404511

Informations de publication

Date de publication:
16 06 2023
Historique:
medline: 19 6 2023
pubmed: 15 6 2023
entrez: 15 6 2023
Statut: ppublish

Résumé

Nocturnal light pollution can have profound effects on humans and other organisms. Recent research indicates that nighttime outdoor lighting is increasing rapidly. Evidence from controlled laboratory studies demonstrates that nocturnal light exposure can strain the visual system, disrupt circadian physiology, suppress melatonin secretion, and impair sleep. There is a growing body of work pointing to adverse effects of outdoor lighting on human health, including the risk of chronic diseases, but this knowledge is in a more nascent stage. In this Review, we synthesize recent research on the context-specific factors and physiology relevant to nocturnal light exposure in relation to human health and society, identify critical areas for future research, and highlight recent policy steps and recommendations for mitigating light pollution in the urban environment.

Identifiants

pubmed: 37319219
doi: 10.1126/science.adg5277
doi:

Substances chimiques

Melatonin JL5DK93RCL

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1130-1135

Auteurs

K M Zielinska-Dabkowska (KM)

GUT LightLab Department of Architecture, Gdańsk University of Technology, 80-233 Gdańsk, Poland.

E S Schernhammer (ES)

Department of Epidemiology, Center for Public Health, Medical University of Vienna, Vienna, 1090, Austria.
Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA 02115, USA.

J P Hanifin (JP)

Department of Neurology, Thomas Jefferson University, Philadelphia, PA 19107, USA.

G C Brainard (GC)

Department of Neurology, Thomas Jefferson University, Philadelphia, PA 19107, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH